# Edenred SE (EDEN.PA) - Investment Thesis v3.0

**Date:** 2026-02-06 (Framework v4.0 Re-evaluation - Brazil Decree Impact)
**Original Date:** 2026-02-01
**Price at Review:** EUR 17.95
**Quality Score:** 62/100 -- Tier B
**Recommendation:** HOLD / WAIT FOR EARNINGS FEB 24
**Framework Version:** 4.0 (Principios Adaptativos)
> **Fair Value:** EUR 29.0 (adversarial, updated 2026-02-07)

---

## Resumen Ejecutivo

Edenred es el lider global en soluciones de pago prepago (meal vouchers, mobility, incentives) con 60M+ usuarios, 2M merchants y 1M clientes corporativos en 45 paises. La accion cotiza a EUR 17.95 (8.7x P/E, 6.8% yield), cerca de su minimo de 52 semanas de EUR 16.96.

**EVENTO MATERIAL v3.0**: El 12 de noviembre 2025, Brasil firmo un decreto regulando el programa PAT de meal vouchers: interchange cap al 2%, settlement reducido de 30 a 15 dias, e interoperabilidad obligatoria en 360 dias. Edenred reviso su guidance de EBITDA 2026 de +2/+4% a -8/-12%. La accion cayo 9% con la noticia. Un tribunal de Sao Paulo concedio injunction suspendiendo la implementacion para Ticket SA (subsidiaria de Edenred), pero el gobierno puede apelar.

A pesar de este golpe, la tesis fundamental sigue intacta: Brasil meal vouchers = 9.5% del revenue del Grupo. El 90.5% restante no esta afectado. El MoS sigue siendo sustancial incluso en escenario Bear. Guidance 2027-2028 (+8/+12% EBITDA) mantenido sin cambios.

---

## SECCION 1: BUSINESS UNDERSTANDING

### 1.1 Modelo de Negocio (sin cambios)

**Que problema resuelve:**
- Para empleadores: administracion eficiente de beneficios (meal vouchers, mobility, incentives) con ventajas fiscales
- Para empleados: acceso a beneficios con red amplia de aceptacion
- Para merchants: trafico garantizado y liquidez predecible
- Es un "must-have": regulacion en muchos paises obliga a ofrecer beneficios

**Como genera ingresos:**
| Tipo Ingreso | % Aprox | Caracteristicas |
|--------------|---------|-----------------|
| Operating revenue (fees + float) | ~85% | Fee por transaccion + intereses sobre float |
| Other revenue | ~15% | Servicios complementarios |

**Tipo dominante:** TRANSACCION + FLOAT (hibrido)
- Recurrencia ALTA: contratos 2-3 anos con renovacion tacita
- Float income: ~EUR 1.3B de float generando ~3-4% de yield

### 1.2 Unit Economics (sin cambios)

```
LTV/CAC Ratio = Estimado >5x (plataforma madura con network effects)
Churn rate: <5% anual (muy bajo)
Retention rate: >95%
Payback Period = <12 meses (negocio maduro)
```

### 1.3 Estructura de Margenes

```
Gross Margin 2024: 42.8% (yfinance) / 45.1% H1 2025 (IR)
  -> Tendencia: ESTABLE (40-45% rango) pero PRESION REGULATORIA creciente
EBITDA margin: 41.1% (EUR 1,174M / EUR 2,856M)
Net Margin 2024: 17.7%

IMPACTO BRASIL (NUEVO v3.0):
  -> Si decreto se implementa: EBITDA -8% a -12% en 2026
  -> Interchange cap 2% reduce fee income en Brasil
  -> Settlement 15 dias (vs 30) reduce float income en Brasil
  -> Brasil meal/food = 9.5% del revenue total
```

### 1.4 Requerimientos de Capital (sin cambios)

**Tipo:** ASSET-LIGHT (plataforma tech + network effects)
- Capex de mantenimiento: ~EUR 100M/ano (~3.5% of revenue)
- Float de EUR 1.3B genera intereses (parcialmente afectado por settlement acelerado en Brasil)

---

## SECCION 2: POR QUE ESTA BARATA (actualizado v3.0)

### 2.1 Narrativa del Mercado (ACTUALIZADA)

| Razon | Status | Mi Evaluacion |
|-------|--------|---------------|
| Declive secular de la industria | NO | Mercado en expansion (digitalizacion) |
| Disrupcion tecnologica (fintechs) | PARCIAL | Swile <5% share, incumbents adaptandose |
| Problemas management/governance | NO | Management competente |
| Balance deteriorandose | PARCIAL | Equity negativo pero Net Debt/EBITDA ~2.3x estable |
| Margenes bajo presion | **SI - INTENSIFICADO** | Italia + Brasil regulacion |
| Perdida market share | NO (vigilar Brasil) | Lider en 70% mercados |
| Riesgo regulatorio | **MUY ALTO** | Italia + Brasil materializado, Francia potencial |
| Guidance decepcionante | **SI - AHORA NEGATIVO** | 2026 de +2/+4% a -8/-12% |
| Sector out-of-favor | SI | De-rating masivo growth -> value |

### 2.2 Mi Contra-Tesis (ACTUALIZADA)

```
Mercado cree: Regulacion destruira el negocio (Italia + Brasil = tendencia imparable)
Yo creo: Regulacion erosiona margenes en mercados especificos pero no destruye el moat global
Mi evidencia:
  - Brasil = 9.5% revenue, no existencial
  - Network effects intactos fuera de Brasil
  - Injunction concedida = base legal para challenge
  - 2027-28 guidance mantenido (+8/+12%)
Probabilidad de equivocado: 35% (SUBIO desde 25% por patron Italia->Brasil)

Mercado cree: 2026 sera catastrofico (-8/-12% EBITDA)
Yo creo: 2026 sera malo pero contenible, 2027+ recovery
Mi evidencia:
  - Injunction puede limitar impacto real
  - Mitigacion measures (pricing, costes) aun no detalladas
  - 90.5% del negocio sigue creciendo
Probabilidad de equivocado: 30%

Mercado cree: Brasil es precedente para Francia
Yo creo: Posible pero no seguro -- Francia es mercado maduro con lobby mas fuerte
Mi evidencia:
  - Italia fue primer precedente, pero Francia no ha actuado en 2+ anos
  - Politica francesa actual pro-business (vs Brasil populista)
Probabilidad de equivocado: 30%
```

### 2.3 Value Trap Checklist (actualizada v3.0)

| Factor | Status | Comentario |
|--------|--------|------------|
| Industria en declive secular | **NO** | Digitalizacion en expansion |
| Disrupcion tecnologica inminente | **NO** | Fintechs son ruido |
| Management destruyendo valor | **NO** | Buybacks a 8x P/E |
| Balance deteriorandose | **PARCIAL** | Equity negativo, Net Debt/EBITDA 2.3x estable |
| Insider selling masivo | **NO** | No detectado |
| Dividend cut probable | **NO** | Payout 60% sostenible aun con -12% EBITDA |
| Perdida market share >2pp | **POSIBLE (Brasil)** | Interoperabilidad podria erosionar en Brasil |
| ROIC < WACC ultimos 3 anos | **NO** | ROIC ~15-18% vs WACC ~8.5% |
| FCF negativo >2 anos | **NO** | FCF consistente EUR 800M+ |
| Goodwill >50% equity | **N/A** | Equity negativo |

**RESULTADO: 1/10 factores confirmado, 1 posible = Bajo riesgo value trap**

---

## SECCION 3: PROYECCION FUNDAMENTADA (ACTUALIZADA v3.0)

### 3.1 Revenue/EBITDA Projection (POST-DECRETO)

```
2025 (estimado):
  EBITDA: ~EUR 1,180-1,200M (guidance pre-decreto cumplido)

2026 (REVISADO POR DECRETO):
  Scenario Range: EBITDA -8% a -12%
  Base: EBITDA ~EUR 1,060-1,090M
  Impacto absoluto: EUR 150-200M negativo vs original

2027-2028 (MANTENIDO por management):
  EBITDA growth: +8% a +12% anual
  Implicacion: recovery a EUR 1,200-1,400M para 2028

2029+: +5% (normalized growth)
```

### 3.2 WACC (sin cambios) = 8.5% (derivado en v2.0)

### 3.3 Terminal Growth = 2.5% (sin cambios)

---

## SECCION 4: VALORACION (ACTUALIZADA v3.0)

### 4.1 Escenarios Post-Decreto

| Escenario | 2026 EBITDA | 2027-28 Recovery | FV Estimate | Prob |
|-----------|-------------|-----------------|-------------|------|
| Bull (injunction holds) | -2% to flat | +10-12% | EUR 50-55 | 20% |
| Base (partial implementation) | -8% to -10% | +8-10% | EUR 38-42 | 50% |
| Bear (full implementation) | -12% to -15% | +5-8% | EUR 25-30 | 25% |
| Disaster (regulation spreads) | -15%+ | <5% | EUR 18-22 | 5% |

**Expected Fair Value = 0.20 x 52.5 + 0.50 x 40 + 0.25 x 27.5 + 0.05 x 20 = EUR 38.4**

### 4.2 DCF Cross-Check

| DCF Scenario | Growth | WACC | Terminal | FV/Share |
|-------------|--------|------|----------|----------|
| Permanent decline (-10%) | -10% | 9% | 2% | EUR 19.29 |
| Rebasing year base (+3%) | 3% | 8.5% | 2.5% | EUR 50.15 |
| Tool default scenarios | 5% | 8.5% | 2.5% | EUR 38-68 |

The permanent decline scenario (EUR 19.29) represents absolute worst case and assumes EBITDA never recovers -- unrealistic given 90.5% of business is unaffected. The base case (EUR 50.15) aligns with pre-decree v2.0 estimates.

### 4.3 Comparacion v2.0 vs v3.0

| Metrica | v2.0 (2026-02-03) | v3.0 (2026-02-06) | Cambio |
|---------|-------------------|-------------------|--------|
| Precio | EUR 17.82 | EUR 17.95 | +0.7% |
| FV Base | EUR 51.5 | EUR 38.4 (expected) | -25.4% |
| FV Bear | EUR 33.5 | EUR 27.5 | -17.9% |
| MoS vs Expected | 65.7% | 53.3% | -12.4pp |
| MoS vs Bear | 46.8% | 34.7% | -12.1pp |
| 2026 EBITDA growth | +2/+4% | -8/-12% | MATERIAL DOWNGRADE |
| 2027-28 guidance | +8/+12% | +8/+12% | UNCHANGED |

### 4.4 Analyst Consensus

- Average target: EUR 29-35 (14-23 analysts)
- Consensus: Buy (16 buy/strong buy, 5 hold, 2 sell)
- Bear (Jefferies): EUR 22.20
- Bull (Kepler Cheuvreux): EUR 40

---

## SECCION 5: MARGIN OF SAFETY

### Precio actual: EUR 17.95
### Fair Value Expected (v3.0): EUR 38.4
### Fair Value Bear (v3.0): EUR 27.5

| Metrica | Valor |
|---------|-------|
| MoS vs Expected FV | (38.4 - 17.95) / 38.4 = **53.3%** |
| MoS vs Bear Case | (27.5 - 17.95) / 27.5 = **34.7%** |
| MoS vs Disaster | (20 - 17.95) / 20 = **10.3%** |

**Tier B precedent MoS: ~20-25% (from decisions_log.yaml)**
**Current MoS of 34.7% vs Bear and 53.3% vs Expected both exceed precedent Tier B requirements.**

---

## SECCION 6: QUALITY SCORE

**Quality Score: 62/100 = Tier B (unchanged from purchase)**

| Component | Score | Notes |
|-----------|-------|-------|
| Financial Quality | 19/40 | ROIC spread 0 pts (tool issue - real ROIC 15-18% vs WACC 8.5%) |
| Growth Quality | 21/25 | Revenue CAGR 15.1%, EPS CAGR 13.2% (historical) |
| Moat Evidence | 17/25 | GM premium +12.8pp, strong market position |
| Capital Allocation | 5/10 | 10yr shareholder returns, low insider ownership |

Note: ROIC spread scored 0 by tool due to yfinance sector classification ("Financial Services"). Real business ROIC of 15-18% vs 8.5% WACC gives true spread of +6.5-9.5pp, which would add 8 points, bringing adjusted QS to ~70.

---

## SECCION 7: RIESGOS & KILL CONDITIONS (ACTUALIZADO v3.0)

### Riesgos Principales (ACTUALIZADOS)

| Riesgo | Severidad | Probabilidad | Cambio vs v2.0 |
|--------|-----------|--------------|-----------------|
| **Regulacion Brasil** | **MUY ALTO** | **MATERIALIZADO** | NEW - era bajo (20%) |
| Regulacion Francia | ALTO | 30% | Sin cambio |
| Regulacion se extiende a otros mercados | ALTO | 25% | NEW |
| Growth no vuelve a 8%+ en 2027 | MEDIO | 30% | Subio de 25% |
| Balance deteriora (decreto + menores ingresos) | MEDIO | 20% | Subio de 15% |
| Fintech disruption | BAJO | 10% | Sin cambio |
| Interoperabilidad Brasil erosiona share | MEDIO | 35% | NEW |

### Kill Conditions (ACTUALIZADAS v3.0)

1. Francia impone interchange caps Y management no presenta plan de mitigacion
2. Net Debt/EBITDA > 3.0x
3. FCF conversion < 50% por 2 anos consecutivos
4. Dividend cut
5. Perdida material de market share (>5pp en 2 anos) en cualquier mercado principal
6. **NEW**: 2027-2028 EBITDA guidance reducido a <+5% (indicaria que impacto Brasil NO esta contenido)
7. **NEW**: Decreto Brasil plenamente ratificado por Supreme Court Y regulacion se extiende a 2+ mercados adicionales

### Kill Conditions Status (2026-02-06)

| Kill Condition | Status | Notes |
|---------------|--------|-------|
| 1. Francia caps | OK | No regulacion anunciada |
| 2. ND/EBITDA >3.0x | OK | Actualmente ~2.3x. Si EBITDA -12%: ~2.6x |
| 3. FCF <50% 2yr | OK | Still >65% |
| 4. Dividend cut | OK | No cut, payout sostenible |
| 5. Share loss >5pp | OK | No evidencia |
| 6. 2027-28 guidance <5% | OK | Mantenido +8/+12% |
| 7. Brasil + spreads | MONITORING | Injunction activa, gobierno puede apelar |

---

## SECCION 8: CATALIZADORES & TIMELINE (ACTUALIZADO)

| Catalizador | Fecha | Probabilidad | Impacto |
|-------------|-------|--------------|---------|
| **FY 2025 results** | **24 Feb 2026** | INMINENTE | MUY ALTO: full year results + Brazil update |
| Injunction appeal resolution | Q1-Q2 2026 | 70% | ALTO: determines actual 2026 impact |
| 2027-28 guidance update | Con earnings Feb 24 | 80% | ALTO: key for re-rating |
| Belgium face value +25% | Q1-Q2 2026 | 90% | Medio: boosts non-Brazil revenue |
| Mitigation plan details | Con earnings Feb 24 | 90% | ALTO: how management adapts |
| Buyback continuation | Ongoing | 70% | Medio: EPS accretion |

### Earnings Feb 24 Decision Tree

```
EARNINGS FEB 24
|
+-- 2027-28 guidance MAINTAINED + Brazil better than feared
|   --> HOLD, consider ADD if price <18 EUR
|
+-- 2027-28 guidance MAINTAINED + Brazil as expected (-8/-12%)
|   --> HOLD, monitor legal process
|
+-- 2027-28 guidance REDUCED (but still >5%)
|   --> Re-evaluate thesis, possible TRIM
|
+-- 2027-28 guidance REDUCED to <5%
|   --> KILL CONDITION #6: Consider EXIT
|
+-- Dividend cut or Net Debt/EBITDA >3.0x
|   --> KILL CONDITION: EXIT
```

### What to Watch on Feb 24

| Data Point | Bull Signal | Bear Signal |
|-----------|-------------|-------------|
| 2025 EBITDA | Above EUR 1,180M | Below EUR 1,100M |
| Brazil revenue Q4 2025 | Stable | Declining |
| Legal update on injunction | Expanded/permanent | Overturned |
| 2026 revised guidance | Better than -8% | Worse than -12% |
| 2027-28 guidance | Maintained +8/+12% | Reduced |
| Other market regulation | None | France/others following |
| FCF conversion | >65% | <60% |
| Net Debt/EBITDA | <2.5x | >3.0x |
| Mitigation plan | Concrete with timeline | Vague |

---

## SECCION 9: DECISION FINAL

### Recomendacion: **HOLD / WAIT FOR EARNINGS FEB 24**

**Razonamiento desde principios (Framework v4.0):**

1. **Principio 6 (Vender requiere argumento):** No hay kill condition triggered. La tesis esta DEBILITADA por el decreto Brasil pero NO INVALIDADA. El 90.5% del negocio sigue intacto. Vender ahora seria vender en el punto de maxima incertidumbre, con earnings en 18 dias que clarificaran materialmente.

2. **Principio 5 (QS como input):** QS 62 (Tier B), sin cambio. Precedentes de Tier B aceptan MoS de 20-25%. Incluso vs Bear case, nuestro MoS es 34.7% -- bien por encima.

3. **Principio 1 (Sizing por conviccion):** Posicion ~4% del portfolio. Si EDEN cae 50% adicional (a EUR ~9), perdemos ~2% del portfolio. Aceptable para Tier B con tesis debilitada pero intacta.

4. **Precedentes consultados (decisions_log.yaml):**
   - SHEL.L HOLD post-earnings con MoS -5% y tesis debilitada: HOLD decision
   - TEP.PA HOLD pre-earnings con MoS 38-51%: HOLD decision
   - EDEN tiene mejor MoS que ambos precedentes, misma logica aplica

**NO ADD porque:**
- Conviccion reducida por decreto Brasil (de 70% a 60%)
- Earnings Feb 24 proporcionara informacion material
- Mejor esperar claridad antes de aumentar exposicion

**NO TRIM/SELL porque:**
- No kill condition triggered
- MoS sustancial incluso en Bear (34.7%)
- Posicion ya pequena (~4%)
- Injunction activa es catalizador positivo
- Vender antes de earnings = vender con maxima incertidumbre

### Targets Actualizados (v3.0)

| Trigger | Precio | Accion |
|---------|--------|--------|
| Post-earnings Bull confirmation | EUR 20-22 | Consider ADD small |
| 80% FV Expected | EUR 30.7 | Vender 25% |
| 100% FV Expected | EUR 38.4 | Vender 50% adicional |
| Kill condition triggered | Any | EXIT |

---

## SECCION 10: AUTOCRITICA (Critical Thinking)

**Asunciones criticas v3.0:**
1. Brasil decreto NO se extiende a Francia (probabilidad: 70%)
2. Management 2027-28 guidance intacto tras decreto (probabilidad: 75%)
3. Injunction tiene base legal solida (probabilidad: 50% -- uncertain)
4. 90.5% del negocio sigue creciendo normalmente (probabilidad: 85%)
5. FCF conversion se mantiene >65% (probabilidad: 75%)

**Sesgos detectados:**
1. **Anchoring**: FV v2.0 era EUR 51.5, v3.0 es EUR 38.4. Posible resistencia a reconocer deterioro completo
2. **Endowment**: Tendencia a HOLD porque ya estamos invertidos. Pregunta: si no tuviera posicion, compraria hoy?
   - Respuesta: SI, a este precio con MoS 53% vs expected FV, compraria una posicion inicial del 3-4%
3. **Confirmation**: Busco evidencia de que injunction resolvera todo. Debo considerar seriamente que gobierno apele y gane.

**Evidencia que podria invalidar:**
1. Francia anuncia regulacion similar
2. Gobierno Brasil apela injunction exitosamente Y implementa decreto completo
3. Management reduce 2027-28 guidance en earnings Feb 24
4. Otros mercados (Mexico, Belgica) siguen a Brasil con regulacion
5. FCF se deteriora por costes legales y reestructuracion

---

## Historial de Cambios

| Version | Fecha | Cambios |
|---------|-------|---------|
| 1.0 | 2026-02-01 | Thesis inicial, BUY recommendation |
| 2.0 | 2026-02-03 | Re-evaluation Framework v2.0. WACC derivado, segundo metodo. FV EUR 51.5 |
| 3.0 | 2026-02-06 | URGENT review: Brazil decree. FV reducido a EUR 38.4 expected. 2026 guidance -8/-12%. Kill conditions expandidas. Status HOLD pre-earnings Feb 24 |
| **4.0** | **2026-02-07** | **Adversarial review. FV revised EUR 38.4 → EUR 29.0 (-24.5%). Italy EUR 120M/yr NOT in FV calculation. Brazil 19% not 9.5%. Kill conditions: 7 → 10. Conviction MEDIUM.** |

---

## ADVERSARIAL REVIEW ADDENDUM (2026-02-07)

> **Review Type:** Adversarial pipeline (risk-identifier + valuation-specialist + review-agent)
> **Trigger:** Adversarial Portfolio Review Fase 1 (earnings urgentes)

### Fair Value Revision

| Metric | Thesis v3.0 | Adversarial | Delta |
|--------|------------|-------------|-------|
| Expected FV | EUR 38.4 | **EUR 29.0** | **-24.5%** |
| Bear FV | EUR 27.5 | **EUR 20.0** | -27.3% |
| MoS at EUR 17.64 | 53.3% | **39.2%** | -14pp |
| MoS vs Bear | 34.7% | **11.8%** | -23pp |
| Italy EBITDA impact | "background" | **EUR 120M/yr NOT in FV** | Material |
| Brazil total exposure | 9.5% | **19% revenue** | Double |

**Working FV: EUR 29.0** (replaces EUR 38.4 for decision-making)

### Key Findings Not in Thesis v3.0
1. **Italy EUR 120M/year impact NOT quantified in FV.** Thesis mentions Italy but does not adjust FV for it. Reduces FV by EUR 3-5/share.
2. **Brazil total exposure 19%, not 9.5%.** The 9.5% is meal/food only. Mobility and corporate payments add another 9.5%.
3. **Cumulative Italy + Brazil = EUR 270-320M, 22-27% of EBITDA.** Correlated regulatory pattern, not isolated events.
4. **Negative equity accelerating**: EUR -809M to EUR -1,046M in 6 months while buyback continues.
5. **Management credibility damaged**: +2/+4% → -8/-12% guidance swing of 10-16pp.

### Verdict: HOLD through earnings Feb 24 | Conviction: MEDIUM

**Reasoning:** ROIC 15-18% >> WACC 9.5% (distinguishes from TEP.PA/LIGHT.AS/PFE sells). MoS 39.2% vs adversarial FV still substantial. No kill conditions triggered. No replacement available. Earnings clarify all material uncertainties in 17 days.

### Post-Earnings Decision Tree
- 2027-28 guidance maintained + Italy manageable --> **HOLD, restore conviction**
- 2027-28 guidance reduced but >5% --> **RE-EVALUATE, possible TRIM**
- 2027-28 guidance <5% --> **EXIT (Kill Condition #6)**
- Dividend cut or Net Debt/EBITDA >3.0x --> **EXIT**
- France regulation announced --> **EXIT (Kill Condition #8)**

### New Kill Conditions (expanded from 7 to 10)
8. Regulation extends to 3rd major market (after Italy + Brazil)
9. Credit rating downgrade to BBB+ or below
10. 2027-28 EBITDA growth delivered at <3% (not just guided)

### Model Disruption Kill Conditions (added 2026-02-11)
11. **Digital wallets eliminate meal voucher model** — If Apple Pay/Google Wallet or a fintech launches employer-subsidized meal payments directly via wallet (bypassing Edenred's closed-loop network) AND captures >15% of any market where Edenred operates, the intermediation model is broken. The moat IS the closed network; direct wallet payments destroy it. Monitor: Apple/Google employer benefit partnerships, fintech meal benefit startups.
12. **Corporate expense platforms absorb Edenred's mobility/corporate payments** — If Brex, Ramp, SAP Concur, or similar expand to cover meal+mobility+corporate benefits in a single platform with >10% penetration in France or LATAM, Edenred's multi-product bundle loses cross-sell advantage. Monitor: corporate card platform expansion into benefits.

---

## Sources

- [Edenred Financial Results](https://www.edenred.com/en/investors-shareholders/financial-results)
- [Edenred: New regulatory framework Brazil](https://media.edenred.com/edenred-takes-note-of-the-new-regulatory-framework-for-the-meal-and-food-voucher-system-in-brazil/?lang=en)
- [Investing.com: Edenred shares fall 9%](https://www.investing.com/news/earnings/edenred-shares-fall-9-after-brazils-new-meal-voucher-rules-threaten-earnings-4350187)
- [MarketScreener: Edenred and Pluxee Shine After Suspension](https://www.marketscreener.com/news/edenred-and-pluxee-shine-amid-temporary-suspension-of-meal-voucher-reform-in-brazil-ce7e58ddd080f427)
- [TradingView: Brazil court suspends meal voucher changes](https://www.tradingview.com/news/reuters.com,2026:newsml_S0N3XN04R:0-brazil-court-suspends-meal-voucher-changes-for-edenred-s-ticket-folha-reports/)
- [TipRanks: Edenred Regulatory Challenges](https://www.tipranks.com/news/ratings/edenred-faces-regulatory-challenges-and-adjusted-growth-forecasts-amidst-brazils-meal-voucher-industry-changes-ratings)
- [Il Sole 24 ORE: Edenred slips to 2017 low](https://en.ilsole24ore.com/art/in-paris-edenred-slips-2017-low-ebitda-guidance-cut-2026-AHqkd7gD)
- [ADVFN: Edenred Brazil Rules Threaten Profitability](https://uk.advfn.com/market-news/article/7941/edenred-shares-slide-as-brazils-new-meal-voucher-rules-threaten-profitability)
- yfinance API (precios y financials)
